You are here:
Publication details
The Plateau of BCR-ABL Transcript Level ≥ 0.1% May Select CML Patients in Complete Cytogenetic Remission for Mutation Analysis
| Authors | |
|---|---|
| Year of publication | 2009 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation |